Cargando…
Reversal of fibrosis in patients with nonalcoholic steatohepatosis after gastric bypass surgery
BACKGROUND: Roux-en-Y gastric bypass (RYGB) improves the pathophysiology that contributes to obesity-related nonalcoholic steatohepatitis (NASH). Whether obesity-related fibrosis improves is unclear. We hypothesized that RYGB reverses NASH and fibrosis, and indocyanine green (ICG) clearance provides...
Autores principales: | Parker, Brian M., Wu, Jiang, You, Jing, Barnes, David S., Yerian, Lisa, Kirwan, John P., Schauer, Philip R., Sessler, Daniel I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596497/ https://www.ncbi.nlm.nih.gov/pubmed/28919979 http://dx.doi.org/10.1186/s40608-017-0168-y |
Ejemplares similares
-
Relation between augmentation index and adiponectin during one-year metformin treatment for nonalcoholic steatohepatosis: effects beyond glucose lowering?
por: Shargorodsky, Marina, et al.
Publicado: (2012) -
Rapidly Resolving Nonalcoholic Marchiafava-Bignami Disease in the Setting of Malnourishment After Gastric Bypass Surgery
por: Bachar, Moshe, et al.
Publicado: (2018) -
Achalasia after bariatric Roux-en-Y gastric bypass surgery reversal
por: Abu Ghanimeh, Mouhanna, et al.
Publicado: (2017) -
Effect of Roux‐en‐Y gastric bypass on liver mitochondrial dynamics in a rat model of obesity
por: Sacks, Jessica, et al.
Publicado: (2018) -
Reversibility of oxalate nephropathy in a kidney transplant recipient with prior gastric bypass surgery
por: Sørensen, Christian Goul, et al.
Publicado: (2021)